UPDATE : Friday, June 23, 2017
Pfizer vows patient access for new breast cancer drug
Pfizer Korea said Friday the company would do its utmost to ensure patient ...
by Constance Williams  |  2017-06-23 13:04
Roche, Celgene fight for No. 1 spot in oncology market
EvaluatePharma, which analyzes pharmaceuticals and biotech companies, said ...
by Marian Chu  |  2017-06-23 11:54
CSL Behring gets FDA approval for rare genetic disease drug
The U.S. Food and Drug Administration Thursday approved Haegarda, CSL Behri...
by Marian Chu  |  2017-06-23 11:44
Why Roche Korea can’t unveil research results of new lung cancer therapy?
Roche Korea is treading carefully in promoting Alecensa (compound: alectini...
by Nam Doo-hyun  |  2017-06-22 16:36
Is Pfizer discriminating against Korean consumers?
Pfizer has come under fire in Korea, as a group of breast cancer patients c...
by Constance Williams  |  2017-06-21 17:17
Hanmi’s R&D workforce increases 9 times in 3 years
Job creation has grown explosively in Hanmi Pharmaceutical’s research and d...
by Marian Chu  |  2017-06-21 15:59
JW Pharmaceutical’s Actemra top choice for rheumatoid arthritis
JW Pharmaceutical said Wednesday that Actemra (Ingredient name: Tosylchemum...
by Constance Williams  |  2017-06-21 14:24
Sanofi fuels competition in 4-strain flu vaccine market
Competition in the quadrivalent influenza vaccine market will likely become...
by Nam Doo-hyun  |  2017-06-21 11:36
Kwangdong tops pharmaceuticals’ 1Q sales list of health food
Kwangdong Pharmaceutical has recorded the highest sales of functional healt...
by Nam Doo-hyun  |  2017-06-20 18:47
New drug to treat glaucoma to hit market soon
DE-117, a new glaucoma therapy being developed by Santen Pharmaceutical산텐제약...
by Lee Hye-seon  |  2017-06-20 16:30
GSK conducts clinical trials for Rotarix without PCV
GlaxoSmithKline (GSK) will conduct clinical trials in Korea of its Rotaviru...
by Lee Hye-seon  |  2017-06-20 12:48
Celltrion’s lymphoma drug proves 97% tumor response rate
The European Phase III trial results for Celltrion’s follicular lymphoma dr...
by Marian Chu  |  2017-06-15 12:38
Orum secures $8 million to develop cell-penetrating antibody technology
Orum Therapeutics, a biotech business, said Wednesday it had received $8 mi...
by Marian Chu  |  2017-06-15 11:25
Pharmaceutical industry wants to use medical big data at public organizations
Drugmakers are raising their voices to ease regulations so that they can ma...
by Nam Doo-hyun  |  2017-06-14 15:46
Novo Nordisk supports people with diabetes through Tour de Korea
Novo Nordisk Pharma employees in Korea hold an in-house support event for T...
by Constance Williams  |  2017-06-14 11:25
Pharmaceutical industry shows low satisfaction with government policy
Korea’s pharmaceutical and biotechnology industries have cited the governme...
by Lee Hye-seon  |  2017-06-13 18:39
US watchdogs take note of corruption in Korean pharmaceuticals
The criminal and civil charges brought against Novartis Korea have directed...
by Marian Chu  |  2017-06-13 16:42
Daewoong hurries to add indications for botox product
Daewoong Pharmaceutical is going all out to add indications to its botulinu...
by Lee Hye-seon  |  2017-06-13 15:51
FTC imposes penalty of W500 million on Novartis Korea
Fair Trade Commission has slapped 500 million won ($440,000) in fines and i...
by Lee Hye-seon  |  2017-06-12 16:39
Patients suffer from side effects after stopping use of Precedex Inj.
The government will include some warnings about nausea, vomit, frequent pul...
by Lee Hye-seon  |  2017-06-12 13:34
Back to Top